RxDoctor Payments Data

Stephanus Busono, MD

Neurology · Somerset, NJNPI 1306888953

Payments from drug & device makers

$50,925in general payments, 2019–2025

Across 1,707 payments — averaging $29.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Argenx US, Inc.$25K
  • Novartis$3K
  • AbbVie$2K
  • Biogen$2K
  • Amneal Pharmaceuticals LLC$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • plus $16K from 54 others

What the payments were for

  • Consulting fees$3001%
  • Speaking & faculty fees$23,47646%
  • Travel & lodging$810%
  • Food & beverage$26,71652%
  • Education$3521%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Argenx US, Inc.112$25,336
Novartis214$2,547
AbbVie(2 entities)207$2,461
Biogen68$1,687
Amneal Pharmaceuticals LLC54$1,382
Teva Pharmaceuticals USA, Inc.95$1,307
Eisai Inc.65$1,016
AstraZeneca(2 entities)47$920
Neurocrine Biosciences, Inc.56$901
Lilly USA, LLC62$892
CSL Behring55$877
Biohaven Pharmaceuticals, Inc.37$833
EMD Serono, Inc.50$804
UCB, Inc.47$758
Genentech USA, Inc.31$649
Amgen(2 entities)31$531
Alnylam Pharmaceuticals Inc.25$452
Supernus Pharmaceuticals, Inc.37$422
SK Life Science, Inc.18$421
Lundbeck LLC19$409
Bristol Myers Squibb27$393
Neurelis, Inc.24$362
Grifols USA, LLC22$357
Sunovion Pharmaceuticals Inc.17$343
Pfizer22$310
E.r. Squibb & Sons, L.L.C.8$304
Vanda Pharmaceuticals Inc.4$263
Kyowa Kirin, Inc.19$259
Axsome Therapeutics, Inc.9$251
Biohaven Pharmaceutical Holding Company Ltd.19$224
Arbor Pharmaceuticals, Inc.16$203
ANI Pharmaceuticals, Inc.12$197
Johnson & Johnson(2 entities)12$184
Impel Pharmaceuticals Inc.13$179
Catalyst Pharmaceuticals, Inc.7$144
Bausch Health US, LLC10$142
Otsuka America Pharmaceutical, Inc.7$119
Boston Scientific6$116
Xeris Pharmaceuticals, Inc.8$112
Avion Pharmaceuticals7$109
Sanofi7$108
Octapharma USA, Inc.7$107
Akcea Therapeutics, Inc.6$106
Upsher-smith Laboratories LLC7$102
Mallinckrodt Hospital Products Inc.6$95
Assertio Therapeutics, Inc.7$91
Amylyx Pharmaceuticals, Inc.4$78
Abbott2$77
Merz North America, Inc.3$75
Almatica Pharma LLC5$68
Cycle Pharmaceuticals Inc3$63
Tanabe Pharma America, Inc.4$59
Jazz Pharmaceuticals Inc.4$55
Acorda Therapeutics, Inc4$54
Adamas Pharmaceuticals, Inc.3$51
C2n Diagnostics, LLC2$46
Scilex Pharmaceuticals Inc.3$45
Merz Pharmaceuticals, LLC3$43
Strongbridge US Inc.3$40
Revance Therapeutics, Inc.2$35

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$50,925 in reported general payments places this provider in the 85th percentile of 521 neurology providers in New Jersey.

See all neurology providers in New Jersey

Medicare billing

Part B allowed, 2024
$368,882
Medicare patients
606
Services billed
13,246

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PrivigenImmun Glob G(Igg)/Pro/Iga 0-5099$2,093,533
GammaplexImmun Glob G(Igg)/Gly/Iga 0-5068$1,744,733
GammakedImmune Globul G/Gly/Iga Avg 4635$716,097
VyvgartEfgartigimod Alfa-Fcab11$592,676
Gamunex-CImmune Globul G/Gly/Iga Avg 4626$399,907
OctagamImmun Globg(Igg)/Malt/Iga Ov5020$390,804
AubagioTeriflunomide12$116,104
IngrezzaValbenazine Tosylate11$91,549
NuplazidPimavanserin Tartrate13$84,806
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5014$81,669
NeuproRotigotine14$15,442
Aimovig AutoinjectorErenumab-Aooe16$14,568
LinzessLinaclotide12$6,611
Memantine Hcl58$3,808
Rasagiline Mesylate20$2,900

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
CSL BehringPrivigen$877$2,093,53399 claims
Argenx US, Inc.Vyvgart$25,336$592,67611 claims
Grifols USA, LLCGamunex-C$357$399,90726 claims
PfizerOctagam$310$390,80420 claims
SanofiAubagio$108$116,10412 claims
Neurocrine Biosciences, Inc.Ingrezza$901$91,54911 claims
UCB, Inc.Neupro$758$15,44214 claims
AbbVieLinzess$2,461$6,61112 claims
Amneal Pharmaceuticals LLCPyridostigmine Bromide$1,382$2,75022 claims
Upsher-smith Laboratories LLCTopiramate$102$34627 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 521 neurology providers in New Jersey.

Other neurology in Somerset

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →